All News

2072 articles, sorted by publication time.

Neuroscience · us

Keeping Brain Stimulation in Step: Early Feasibility Signals Emerge for Walking Treatment in Parkinson’s Disease

A small randomized feasibility trial moved deep brain stimulation from “continuous playback” toward “gait-adjusted” stimulation. The results show that the device can align with walking rhythm according to individual neural signals and reduced falls in a small number of patients; however, this remains a technical validation, not a definitive conclusion on efficacy.

Biopharma · global

Phase 3 trial success for BTK inhibitor remibrutinib adds an oral route for chronic spontaneous urticaria treatment

For patients with chronic urticaria that recurs repeatedly and has hard-to-identify causes, relieving itch and clearing wheals is often more than a matter of comfort. Novartis has announced results from two Phase 3 studies pointing to an oral small-molecule therapy targeting immune signaling, but full data and long-term safety remain key to interpretation.

Genomic Medicine · us

A CRISPR Therapy Tailored for One Infant Pushes Rare-Disease Medicine Past a Personalization Threshold

An infant with severe CPS1 deficiency received an in vivo base-editing treatment designed specifically for his mutation, with the process from diagnosis to clinical use completed in about six months. This is not a routine therapy that can be immediately replicated, but it pushes the treatment imagination for ultra-rare diseases toward a new clinical frontier.